Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
27.1M
-
Number of holders
-
131
-
Total 13F shares, excl. options
-
19.9M
-
Shares change
-
+915K
-
Total reported value, excl. options
-
$735M
-
Value change
-
+$29.6M
-
Put/Call ratio
-
0.31
-
Number of buys
-
54
-
Number of sells
-
-75
-
Price
-
$37.01
Significant Holders of Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) as of Q4 2021
174 filings reported holding ARCT - Arcturus Therapeutics Holdings Inc. - Common Stock as of Q4 2021.
Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) has 131 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.9M shares
of 27.1M outstanding shares and own 73.42% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (3.69M shares), ARK Investment Management LLC (2.47M shares), STATE STREET CORP (2.06M shares), BlackRock Inc. (1.76M shares), Sumitomo Mitsui Trust Holdings, Inc. (1.36M shares), Nikko Asset Management Americas, Inc. (1.36M shares), VANGUARD GROUP INC (1.15M shares), FMR LLC (921K shares), ACT CAPITAL MANAGEMENT, LLC (479K shares), and GEODE CAPITAL MANAGEMENT, LLC (375K shares).
This table shows the top 131 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.